Company: PMVP
Filing Date: 2025-05-09
Form Type: 8-K
Source: 0000950170-25-067511
Chunk: 1

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-05-09
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

  Exhibit      Description                                                                   
                                                                                             
   Number                                                                                    
     99.1      Press Release issued by PMV Pharmaceuticals, Inc., dated May 9, 2025.         
 ─────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                         PMV Pharmaceuticals, Inc.                                                    
  Date: May 9, 2025      By:                            /s/ Michael Carulli                           
                                                        Michael Carulli                               
                                                        Chief Financial Officer